Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in Pheochromocytoma and paraganglioma

Journal of Nuclear Medicine

Volumn 55, Issue 8, 2014, Pages 1253-1259

  Van Berkel, Anouk ^a   Rao, Jyotsna U ^a   Kusters, Benno ^a,b   Demir, Tuna ^a   Visser, Eric ^a   Mensenkamp, Arjen R ^a   Van Der Laak, Jeroen A W M ^a   Oosterwijk, Egbert ^a   Lenders, Jacques W M ^a,c   Sweep, Fred C G J ^a   Wevers, Ron A ^a   Hermus, Ad R ^a   Langenhuijsen, Johan F ^a   Kunst, Dirk P M ^a   Pacak, Karel ^d   Gotthardt, Martin ^a   Timmers, Henri J L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Paraganglioma; Pheochromocytoma; Succinate dehydrogenase; Warburg effect

Indexed keywords

CD34 ANTIGEN; DIAMINOBENZIDINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; HEXOKINASE; HEXOKINASE 1; HEXOKINASE 2; HEXOKINASE 3; MONOCARBOXYLATE TRANSPORTER 4; PEROXIDASE; PROTEIN RET; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; VASCULOTROPIN; BIOLOGICAL MARKER; GLUCOSE;

ADULT; ANALYTICAL PARAMETERS; ANGIOGENESIS; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUT 3 GENE; GLYCOLYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MUTATIONAL ANALYSIS; MYC ASSOCIATED FACTOR X GENE; NEUROFIBROMATOSIS; NF1 GENE; ONCOGENE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMERIZATION; RET GENE; SDHB GENE; SDHD GENE; SDHX GENE; STANDARDIZED UPTAKE VALUE; TUMOR LOCALIZATION; UPREGULATION; ADRENAL TUMOR; DIAGNOSTIC USE; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; SCINTISCANNING; TRANSPORT AT THE CELLULAR LEVEL;

ADRENAL GLAND NEOPLASMS; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 84905462359     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.114.137034     Document Type: Article

References (34)

1. Gimenez-Roqueplo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res. 2012;44:328-333.
2. Eisenhofer G, Huynh TT, Pacak K, et al. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocr Relat Cancer. 2004;11:897-911.
3. López-Jiménez E, Gomez-Lopez G, Leandro-Garcia LJ, et al. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas. Mol Endocrinol. 2010;24:2382-2391.
4. 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94:4757-4767.
5. 18FFDG) positron emission tomography. J Natl Cancer Inst. 2012;104:700-708.
6. Timmers HJ, Kozupa A, Chen CC, et al. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol. 2007;25:2262-2269.
7. 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med. 2009;50:711-717.
8. Blanchet EM, Gabriel S, Martucci V, et al. F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas. Eur J Clin Invest. 2014;44:325-332.
9. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J Clin Endocrinol Metab. 2002;87:4771-4774.
10. Favier J, Briere JJ, Burnichon N, et al. The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS ONE. 2009;4:e7094.
11. Rao JU, Engelke UF, Rodenburg RJ, et al. Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma. Clin Cancer Res. 2013;19:3787-3795.
12. Jochmanová I, Yang C, Zhuang Z, Pacak K. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst. 2013;105:1270-1283.
13. Gordan JD, Simon MC. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev. 2007;17:71-77.
14. Dahia PL, Familial Pheochromocytoma C. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas. Ann N Y Acad Sci. 2006;1073:208-220.
15. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 2005;7:77-85.
16. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
17. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654-662.
18. Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol. 2009;19:17-24.
19. Ahn KJ, Hwang HS, Park JH, et al. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines. J Nucl Med. 2009;50:1525-1532.
20. Yamada T, Uchida M, Kwang-Lee K, et al. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:464-471.
21. de Geus-Oei LF, van Krieken JH, Aliredjo RP, et al. Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer. 2007;55:79-87.
22. Wyatt E, Wu R, Rabeh W, Park HW, Ghanefar M, Ardehali H. Regulation and cytoprotective role of hexokinase III. PLoS ONE. 2010;5:e13823.
23. Dierckx RA, Van de Wiele C. FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging. 2008;35:1544-1549.
24. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med. 1995;36:1625-1632.
25. Boellaard R, O'Doherty MJ, Weber WA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37:181-200.
26. Eisenhofer G, Pacak K, Huynh TT, et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2011;18:97-111.
27. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029-1033.
28. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399-408.
29. 18F-FDG uptake in human endothelial cells in vitro. J Nucl Med. 2004;45:455-460.
30. Blank A, Schmitt AM, Korpershoek E, et al. SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling. Endocr Relat Cancer. 2010;17:919-928.
31. Aloj L, Caraco C, Jagoda E, Eckelman WC, Neumann RD. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res. 1999;59:4709-4714.
32. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential. Int J Hematol. 2013;97:43-49.
33. Wolf A, Agnihotri S, Micallef J, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208:313-326.
34. Span PN, Rao JU, Oude Ophuis SB, et al. Overexpression of the natural antisense hypoxia-inducible factor-1a transcript is associated with malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2011;18:323-331.